Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUILS: Rocuronium Use in Lumbar Surgery
NCT05619848Phase 1Completed
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rocuronium in lumbar spinal stenosis (LSS) (3 arms). Primary endpoint: Use of rocuronium bromide. Started Oct 2022; status: completed.
02
Drugs
rocuronium
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on NCT05619848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05619848.